Float Short %

5.42

Margin Of Safety %

-2

Put/Call OI Ratio

0.3

EPS Next Q Diff

0.24

EPS Last/This Y

0.87

EPS This/Next Y

0.11

Price

31.14

Target Price

43.73

Analyst Recom

1.62

Performance Q

-24.23

Relative Volume

0.7

Beta

2.05

Ticker: VCYT

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-20	VCYT	31.81	0.09	0.60	3107
2025-03-21	VCYT	31.84	0.09	1.94	3107
2025-03-24	VCYT	33.18	0.26	0.02	838
2025-03-25	VCYT	33.69	0.26	0.00	855
2025-03-26	VCYT	31.15	0.26	10.00	852
2025-03-27	VCYT	31.09	0.31	0.00	908
2025-03-28	VCYT	30.12	0.30	999.99	920
2025-03-31	VCYT	29.64	0.30	999.99	920
2025-04-01	VCYT	29.53	0.31	0.17	921
2025-04-02	VCYT	30.14	0.30	0.43	947
2025-04-03	VCYT	28.47	0.30	0.00	952
2025-04-04	VCYT	28.75	0.30	0.50	953
2025-04-07	VCYT	29.53	0.30	0.45	950
2025-04-08	VCYT	28.89	0.29	1.50	968
2025-04-09	VCYT	32.63	0.29	0.90	970
2025-04-10	VCYT	30.25	0.29	0.00	980
2025-04-11	VCYT	31.8	0.29	0.00	980
2025-04-14	VCYT	32.19	0.29	0.00	982
2025-04-15	VCYT	31.75	0.29	1.11	985
2025-04-16	VCYT	31.52	0.30	999.99	1003
2025-04-17	VCYT	31.15	0.30	0.00	1004
2025-04-18	VCYT	31.14	0.30	0.00	1004
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-20	VCYT	31.84	435.2	70.5	1.19
2025-03-21	VCYT	31.82	435.2	70.2	1.19
2025-03-24	VCYT	33.16	435.2	74.6	1.19
2025-03-25	VCYT	33.69	435.2	71.9	1.19
2025-03-26	VCYT	31.05	435.2	61.9	1.19
2025-03-27	VCYT	31.07	435.2	70.3	1.19
2025-03-28	VCYT	30.12	435.2	66.9	1.19
2025-03-31	VCYT	29.65	435.2	68.6	1.19
2025-04-01	VCYT	29.56	435.2	69.9	1.19
2025-04-02	VCYT	30.13	435.2	72.3	1.19
2025-04-03	VCYT	28.47	435.2	64.4	1.19
2025-04-04	VCYT	28.95	435.2	72.1	1.19
2025-04-07	VCYT	29.54	435.2	72.6	1.19
2025-04-08	VCYT	28.88	435.2	67.9	1.19
2025-04-09	VCYT	32.62	435.2	84.1	1.19
2025-04-10	VCYT	30.26	435.2	62.6	1.19
2025-04-11	VCYT	31.80	430.5	75.7	1.19
2025-04-14	VCYT	32.14	430.5	71.4	1.19
2025-04-15	VCYT	31.76	430.5	69.0	1.19
2025-04-16	VCYT	31.50	430.5	69.4	1.19
2025-04-17	VCYT	31.14	428.1	68.9	1.19
2025-04-18	VCYT	31.14	428.1	70.2	1.19
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-20	VCYT	-9.50	-2.98	4.41
2025-03-21	VCYT	-9.50	-2.98	4.41
2025-03-24	VCYT	-9.11	-2.96	4.41
2025-03-25	VCYT	-9.11	-2.96	4.41
2025-03-26	VCYT	-9.11	-2.96	4.30
2025-03-27	VCYT	-9.11	-2.96	4.30
2025-03-28	VCYT	-9.11	-2.96	4.30
2025-03-31	VCYT	-9.11	-2.96	4.30
2025-04-01	VCYT	-9.11	-2.96	4.30
2025-04-02	VCYT	-9.11	-2.96	4.30
2025-04-03	VCYT	-9.11	-2.96	4.30
2025-04-04	VCYT	-9.11	-2.96	4.30
2025-04-07	VCYT	-9.11	-2.96	4.30
2025-04-08	VCYT	-9.11	-2.96	4.30
2025-04-09	VCYT	-9.11	-2.96	4.30
2025-04-10	VCYT	-9.11	-2.96	5.42
2025-04-11	VCYT	-9.11	-2.96	5.42
2025-04-14	VCYT	-9.11	-2.98	5.42
2025-04-15	VCYT	-9.11	-2.98	5.42
2025-04-16	VCYT	-9.11	-2.98	5.42
2025-04-17	VCYT	-9.11	-2.98	5.42
2025-04-18	VCYT	-9.11	-2.98	5.42
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.06

Avg. EPS Est. Current Quarter

0.2

Avg. EPS Est. Next Quarter

0.3

Insider Transactions

-9.11

Institutional Transactions

-2.98

Beta

2.05

Average Sales Estimate Current Quarter

110

Average Sales Estimate Next Quarter

121

Fair Value

30.41

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

63.8

Max Drawdown 5-Year %

-81.2

Target Price

43.73

P/E

101.6

Forward P/E

44.85

PEG

2.4

P/S

5.45

P/B

2.06

P/Free Cash Flow

38.04

EPS

0.31

Average EPS Est. Cur. Y

1.19

EPS Next Y. (Est.)

1.3

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

5.41

Relative Volume

0.7

Return on Equity vs Sector %

-17.9

Return on Equity vs Industry %

-8.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

70.2

Veracyte, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 824

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

stock quote shares VCYT – Veracyte, Inc. Stock Price stock today

news today VCYT – Veracyte, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VCYT – Veracyte, Inc. yahoo finance google finance

stock history VCYT – Veracyte, Inc. invest stock market

stock prices VCYT premarket after hours

ticker VCYT fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: VCYT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y